Page 29 - 01.pdf

STATEMENT OF
CORPORATE GOVERNANCE
ASIAMEDIC LIMITED
ANNUAL REPORT 2013 27
The Company’s AGMs are the principal forums for dialogue with shareholders. The Chairmen of the various Board
Committees are normally available at the meetings to answer any question relating to the work of the Board Committees.
The external auditors shall also be present to assist the Directors in addressing any relevant queries by the shareholders.
Shareholders are encouraged to attend the AGMs and the EGMs to ensure a high level of accountability and to
stay apprised of the Group’s strategy and goals. Notices of the meetings will be advertised in the newspapers and
announced on the SGXNET.
The Company’s Articles of Association allows all shareholders to appoint up to two proxies to attend general meetings
and vote on their behalf.
The details of dividend payment to shareholders will be disclosed via the release of the announcements through
SGXNET. For FY2013, no dividend is declared or recommended due to the performance of the Group.
DEALINGS IN SECURITIES
In line with Rule 1204(19) of the Catalist Rules, the Company issues circulars to its Directors and employees to remind
them that (1) they should not deal in shares of the Company on short-term considerations or if they are in possession
of unpublished material price-sensitive information; and (2) they are required to report on their dealings in shares of
the Company. The Directors and employees are also reminded of the prohibition in dealing in shares of the Company
one month before the announcement of the Group’s half-year and year-end financial statements. The restriction in
dealings in securities is also extended to employees of the Group.
INTERESTED PERSON TRANSACTIONS
The Company adopted an internal policy in respect of any transactions with interested persons and has established
procedures for review and approval of the interested person transactions entered into by the Group. The ARMC has
reviewed the rationale and terms of the Group’s interested person transactions and is of the view that the interested
person transactions are on normal commercial terms and are not prejudicial to the interests of the shareholders.
There are no reportable interested person transactions for FY2013.
MATERIAL CONTRACTS
There were no material contracts entered into by the Company or any of its subsidiary companies involving the interest
of the CEO, Director, or controlling shareholder.
NON-AUDIT FEES AND NON-SPONSOR FEES
There were no non-audit fees and non-sponsor fees paid to the external auditors and sponsor respectively.